Pfenex Inc. and ProZyme, Inc. have entered into a joint collaboration and supply agreement in which they will develop and manufacture a range of value-added proteins which will be marketed and sold to customers in the research and diagnostics market space. Pfenex will provide ProZyme with exclusive access to the Pfēnex Expression Technology platform for the production of an initial set of three undisclosed proteins. Pfenex will be responsible for developing production strains, fermentation proc...